Retail Clinics

NEW YORK — Consumers that seek timely and detailed information about product recalls look to multiple resources, according to a new Deloitte survey.

JOHNSON CITY, N.Y. — A Native American tribal clinic in Redding, Calif., that fills some 300 prescriptions per day has adopted a pharmacy automation system made by Innovation, the company said Friday.

ATLANTA — The Centers for Disease Control and Prevention is participating in a new docudrama that debuts on Animal Planet beginning Friday at 9 p.m., the agency announced earlier this week.

Animal Planet has ordered six episodes of the new series “Killer Outbreaks.” Each episode features potentially deadly viruses and includes commentary from CDC experts and victims of the outbreaks. "Killer Outbreaks" began production in March 2010, and in total, producers interviewed 43 subject matter experts from across the agency.

DEERFIELD, Ill. — Takeda Pharmaceutical has launched a new treatment for high blood pressure, the company said Friday.

Takeda announced the launch of Edarbi (azilsartan medoxomil), which the Food and Drug Administration approved on Feb. 25 as a once-daily pill for hypertension.

BRENTWOOD, Tenn. ­— The Little Clinic has announced the appointment of Kenneth Patric as its new chief medical officer, providing medical oversight and management, and overseeing the development and implementation, of new clinical programs and initiatives for The Little Clinic on a national level.

ATLANTA — The National Center for Health Statistics earlier this month issued a report showing that use of dietary supplements has been on an upward trajectory over the past decade — only 40% of Americans took supplements in 1988, compared with 53% who took supplements in 2006.

WASHINGTON — The congressional Dietary Supplement Caucus held its first briefing for the 112th Congress April 6 to a capacity crowd of 60 House and Senate staffers, the caucus announced Thursday.

The DSC recently was relaunched for the 112th Congress. The caucus serves as a bipartisan, bicameral group of members to facilitate discussions among lawmakers about the benefits of dietary supplements, provide tips and insights for better health and wellness, and promote research into the healthcare savings provided by dietary supplements.

HYDERABAD, India — The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.

Dr. Reddy's fexofenadine HCl tablets are bioequivalent versions of Sanofi-Aventis’ Allegra, which received Rx-to-OTC switch approval from the FDA in January.

The fexofenadine HCl Rx market had branded and generic sales of approximately $452 million for the 12 months ended last December, according to IMS Health.